Specialty medicines

LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...

DEERFIELD, Illinois & BARCELONA, Spain — March 11, 2026 The global pharmaceutical industry marked an important strategic development as...

September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...